Skip to main content
. 2017 May 25;17:66. doi: 10.1186/s12871-017-0363-x

Table 4.

Incidence of adverse events

Parameter Group S (n = 29) Group SD (n = 29)
Nausea 6 (20.6) 5 (17.2)
Vomiting 2 (6.8) 3 (10.3)
Pruritus 6 (20.6) 3 (10.3)
Uninary retention 0 0
Severe sedation 0 0

Values are given as number of subjects (%)

S sufentanil group, SD sufentanil/dexmedetomidine group